Cost effectiveness of pramipexole in Parkinson's disease in the US

Thomas Hoerger; Mohan Bala; C Rowland; M Greer; EA Chrischilles; RG Holloway

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Cost effectiveness of pramipexole in Parkinson's disease in the US

Hoerger, T., Bala, M., Rowland, C., Greer, M., Chrischilles, EA., & Holloway, RG. (1998). Cost effectiveness of pramipexole in Parkinson's disease in the US. PharmacoEconomics, 14(5), 541-557.

Copy citation

Recent Publications

OCCASIONAL PAPER

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers

Cost effectiveness of pramipexole in Parkinson's disease in the US

Publications Info

Thomas J. Hoerger

Recent Publications

Bringing an equity-centered framework to research

The Preschool Entitlement

Culturally informed community engagement

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers

Partner With Us

Site

Cost effectiveness of pramipexole in Parkinson's disease in the US

Publications Info

Meet the Experts

Thomas J. Hoerger

Recent Publications

Bringing an equity-centered framework to research

The Preschool Entitlement

Culturally informed community engagement

Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers